BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23012362)

  • 1. Identification of molecular switch regulating interactions of Janus kinase 3 with cytoskeletal proteins.
    Mishra J; Karanki SS; Kumar N
    J Biol Chem; 2012 Nov; 287(49):41386-91. PubMed ID: 23012362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Janus kinase 3 regulates interleukin 2-induced mucosal wound repair through tyrosine phosphorylation of villin.
    Kumar N; Mishra J; Narang VS; Waters CM
    J Biol Chem; 2007 Oct; 282(42):30341-5. PubMed ID: 17537734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adapter protein Shc regulates Janus kinase 3 phosphorylation.
    Mishra J; Kumar N
    J Biol Chem; 2014 Jun; 289(23):15951-6. PubMed ID: 24795043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Janus kinase 3 regulates adherens junctions and epithelial mesenchymal transition through β-catenin.
    Mishra J; Das JK; Kumar N
    J Biol Chem; 2017 Oct; 292(40):16406-16419. PubMed ID: 28821617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential molecular mechanism for c-Src kinase-mediated regulation of intestinal cell migration.
    Mathew S; George SP; Wang Y; Siddiqui MR; Srinivasan K; Tan L; Khurana S
    J Biol Chem; 2008 Aug; 283(33):22709-22. PubMed ID: 18482983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of phospholipase C-gamma(1) by the actin-regulatory protein villin.
    Panebra A; Ma SX; Zhai LW; Wang XT; Rhee SG; Khurana S
    Am J Physiol Cell Physiol; 2001 Sep; 281(3):C1046-58. PubMed ID: 11502583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of actin dynamics by tyrosine phosphorylation: identification of tyrosine phosphorylation sites within the actin-severing domain of villin.
    Zhai L; Kumar N; Panebra A; Zhao P; Parrill AL; Khurana S
    Biochemistry; 2002 Oct; 41(39):11750-60. PubMed ID: 12269817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Janus kinase 3 in mucosal differentiation and predisposition to colitis.
    Mishra J; Verma RK; Alpini G; Meng F; Kumar N
    J Biol Chem; 2013 Nov; 288(44):31795-806. PubMed ID: 24045942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected effects of FERM domain mutations on catalytic activity of Jak3: structural implication for Janus kinases.
    Zhou YJ; Chen M; Cusack NA; Kimmel LH; Magnuson KS; Boyd JG; Lin W; Roberts JL; Lengi A; Buckley RH; Geahlen RL; Candotti F; Gadina M; Changelian PS; O'Shea JJ
    Mol Cell; 2001 Nov; 8(5):959-69. PubMed ID: 11741532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: evidence for interactions between the kinase and pseudokinase domains.
    Chen M; Cheng A; Candotti F; Zhou YJ; Hymel A; Fasth A; Notarangelo LD; O'Shea JJ
    Mol Cell Biol; 2000 Feb; 20(3):947-56. PubMed ID: 10629052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pseudokinase domain is required for suppression of basal activity of Jak2 and Jak3 tyrosine kinases and for cytokine-inducible activation of signal transduction.
    Saharinen P; Silvennoinen O
    J Biol Chem; 2002 Dec; 277(49):47954-63. PubMed ID: 12351625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor STAT5A is a substrate of Bruton's tyrosine kinase in B cells.
    Mahajan S; Vassilev A; Sun N; Ozer Z; Mao C; Uckun FM
    J Biol Chem; 2001 Aug; 276(33):31216-28. PubMed ID: 11413148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cell motility by tyrosine phosphorylated villin.
    Tomar A; Wang Y; Kumar N; George S; Ceacareanu B; Hassid A; Chapman KE; Aryal AM; Waters CM; Khurana S
    Mol Biol Cell; 2004 Nov; 15(11):4807-17. PubMed ID: 15342783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine phosphorylation of villin regulates the organization of the actin cytoskeleton.
    Zhai L; Zhao P; Panebra A; Guerrerio AL; Khurana S
    J Biol Chem; 2001 Sep; 276(39):36163-7. PubMed ID: 11500485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of function mutations in PTPN6 promote STAT3 deregulation via JAK3 kinase in diffuse large B-cell lymphoma.
    Demosthenous C; Han JJ; Hu G; Stenson M; Gupta M
    Oncotarget; 2015 Dec; 6(42):44703-13. PubMed ID: 26565811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of the phosphorylation states of pp60c-src with tyrosine kinase activity: the intramolecular pY530-SH2 complex retains significant activity if Y419 is phosphorylated.
    Boerner RJ; Kassel DB; Barker SC; Ellis B; DeLacy P; Knight WB
    Biochemistry; 1996 Jul; 35(29):9519-25. PubMed ID: 8755732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Janus kinases in interleukin-2-mediated signaling: JAK1 and JAK3 are differentially regulated by tyrosine phosphorylation.
    Liu KD; Gaffen SL; Goldsmith MA; Greene WC
    Curr Biol; 1997 Nov; 7(11):817-26. PubMed ID: 9382798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional dissection and molecular characterization of calcium-sensitive actin-capping and actin-depolymerizing sites in villin.
    Kumar N; Tomar A; Parrill AL; Khurana S
    J Biol Chem; 2004 Oct; 279(43):45036-46. PubMed ID: 15272027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of villin with phosphatidylinositol 4,5-bisphosphate regulates the actin cytoskeleton.
    Kumar N; Zhao P; Tomar A; Galea CA; Khurana S
    J Biol Chem; 2004 Jan; 279(4):3096-110. PubMed ID: 14594952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct Acute Lymphoblastic Leukemia (ALL)-associated Janus Kinase 3 (JAK3) Mutants Exhibit Different Cytokine-Receptor Requirements and JAK Inhibitor Specificities.
    Losdyck E; Hornakova T; Springuel L; Degryse S; Gielen O; Cools J; Constantinescu SN; Flex E; Tartaglia M; Renauld JC; Knoops L
    J Biol Chem; 2015 Nov; 290(48):29022-34. PubMed ID: 26446793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.